• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

Medical News Interviews

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

AACR In New Partnership For San Antonio Breast Cancer Symposium

0
  • by alexperjescuadmin
  • in News
  • — 14 Dec, 2007
AACR In New Partnership For San Antonio Breast Cancer Symposium
AudioMedica News
AACR In New Partnership For San Antonio Breast Cancer Symposium
AACR In New Partnership For San Antonio Breast Cancer Symposium
00:00 /
RSS Feed
Share
Link
Embed
//-->//>' class="input-embed input-embed-392"/>
Margaret Foti
Margaret Foti

MARGARET FOTI, American Association for Cancer Research, Philadelphia
The San Antonio Breast Cancer Symposium will, in the future, be presented jointly by the Cancer Therapy and Research Center at the University of Texas Health Science Center, Baylor College of Medicine, and the American Association for Cancer Research. Peter Goodwin found out more on this new collaboration from Margaret Foti, CEO of the American Association for Cancer Research in Philadelphia.



LISTEN

[audio:https://www.audiomedica.com/podcasting/oncology/071213_margeret_foti.mp3]

Share

Tags: aacrantonio breast cancer symposiumbaylor college of medicinebreast cancer symposiumbreast-cancercancer researchcancer therapycollege of medicinefotihealth science centeriphonemargeretOncologypeter goodwinsan antonio breastsan antonio breast cancersan antonio breast cancer symposiumtexas health sciencetexas health science centeruniversity of texas health science center

You may also like...

  • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen. MMR vaccine’s non-specific effects: adherence to recommended vaccination schedules protects children against non-vaccination-specific infections too 28 Feb, 2014
  • Liver Cancer: Risk Groups for Screening Liver Cancer: Risk Groups for Screening 27 Jan, 2008
  • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen. Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer risk 6 Mar, 2014
  • Quitting smoking cuts risk of cataract Big orteronel study: prostate hopes 6 Feb, 2014

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story Early Breast Cancer: Survival Benefit For Adjuvant Docetaxel/Cyclophosphamide
  • Next story New Drug RAD001 Plus Letrozole In Neoadjuvant Therapy For Breast Cancer
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Microbiome Diversity Key To Survival After…
    • Ibrutinib: New Frontline Standard for Chronic…
    • Genomic-led AML Clinical Decision Making Within Seven Days
    • Brachytherapy “Excellent” After Breast…
    • Polygenic Risk Scores Could Help Predict Second…
  • Home
  • News
  • AACR In New Partnership For San Antonio Breast Cancer Symposium

© Copyright 2021 AudioMedica.com. Typegrid Theme by WPBandit.